A case for integrated morphomolecular diagnostic pathologists

Clinical Chemistry

Volumn 53, Issue 7, 2007, Pages 1188-1190

  Salto Tellez, Manuel ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; T LYMPHOCYTE RECEPTOR;

BRAIN TUMOR; BREAST CANCER; CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CHROMOSOME TRANSLOCATION; CLINICAL PRACTICE; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENE REARRANGEMENT; GENOME; HUMAN; LUNG CANCER; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR BIOLOGY; NOTE; ONCOGENE NEU; PATHOLOGIST; POLYMERASE CHAIN REACTION; SARCOMA; UTERINE CERVIX CANCER; VIRUS TYPING; WART VIRUS;

GENE EXPRESSION PROFILING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PATHOLOGY, CLINICAL; PHARMACOGENETICS; SURGICAL PROCEDURES, OPERATIVE;

EID: 34347404283     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.088088     Document Type: Note

References (15)

1. Heffner DK. The end of surgical pathology. Ann Diagn Pathol 2001;5:368-73.
2. Rosai J. The continuing role of morphology in the molecular age. Mod Pathol 2001;14:258-60.
3. Bagg A. Molecular diagnosis in lymphoma. Curr Hematol Rep 2005;4:313-23.
4. Salto-Tellez M, Lee SC, Chiu LL, Lee CK, Yong MC, Koay ESC. Microsatellite instability in colorectal cancer: considerations for molecular diagnosis and high-throughput screening of archival tissues. Clin Chem 2004;50:1082-6.
5. Zhang DH, Salto-Tellez M, Putti TC, Do E, Koay ESC. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol 2003;16:79-85.
6. Chin TM, Anuar D, Soo R, Salto-Tellez M, Li WQ, Ahmad B, et al. Detection of epidermal growth factor receptor variations by partially denaturing HPLC. Clin Chem 2007;53:62-70.
7. Sequist LV, Joshi VA, Janne PA, Bell DW, Fidias P, Lindeman NI, et al. Epidermal growth factor receptor mutation testing in the care of lung cancer patients. Clin Cancer Res 2006;12:4403s-8s.
8. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003;21:4342-9.
9. McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, et al. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer 2005;104:1468-77.
10. Yeoh GP, Tse MP, Chan KW, Lord L. Human papillomavirus DNA and liquid-based cervical cytology cotesting in screening and follow-up patient groups. Acta Cytol 2006;50:627-31.
11. Tomescu O, Barr FG. Chromosomal translocations in sarcomas: prospects for therapy. Trends Mol Med 2001;7:554-9.
12. Salto-Tellez M, Zhang D, Chiu LL, Wang SC, Nilsson B, Koay ES. Immunocytochemistry versus molecular fingerprinting of metastases. Cytopathology 2003;14:186-90.
13. Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N, et al. Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 2006;7:278.
14. Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.
15. Gurwitz D, Lunshof JE, Altman RB. A call for the creation of personalized medicine databases. Nat Rev Drug Discov 2006;5:23-6.